Endo International plc (NASDAQ:ENDP) shares are up nearly 3% in Monday’s trading session, after the drug maker pre-announced Q3 EPS of $0.85, solidly above …
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 19% …
Jason Kolbert believes that OMER’s OMS721 flashes an upper hand over competitor Soliris drug.
Aviragen Therapeutics Inc (NASDAQ:AVIR) and Vaxart announced the signing of a definitive merger agreement, which will result in a combined company, Vaxart, Inc., …
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that indoximod, its investigational drug candidate, was granted orphan-drug designation by the U.
Cory Kasimov is enthusiastic on GILD’s CAR-T therapy Yescarta as well as M&A strategy.
It’s been a good day for shareholders of tiny-size biotech company Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB). Shares of Navidea spiked sharply Friday after the …
Shares of Celsion Corporation (NASDAQ:CLSN) dived nearly 20% in morning trade Friday, after the drug maker’s stock offering priced at a deep discount. The …
Louise Chen notes that under OPK’s agreement with Tesaro, the approval of Varubi IV is a huge win.
Louise Chen: The Street has not fully valued what global generics rivalry will mean for TEVA’s Copaxone.
